Sponsor

amfAR, The Foundation for AIDS Research

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name amfAR, The Foundation for AIDS Research appears in 25 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials25
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

25 shown
HCV Treatment in HIV Co-Infected Patients in AsiaNCT01838772 · lead sponsor · 2013-12-01
COMPLETED
Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEXNCT07505875 · collaborator · 2024-05-01
RECRUITING
Interleukin-15 to Promote Post-ART Control of HIVNCT07145164 · collaborator · 2025-08-19
ENROLLING_BY_INVITATION
The South-East Asian Transgender Health CohortNCT05454579 · collaborator · 2022-12-02
COMPLETED
Implementation of a Collaborative Care Model to Manage Depression Among Adolescents and Young Adults in HIV Services in ThailandNCT05006625 · collaborator · 2021-10-01
COMPLETED
COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIVNCT04958889 · collaborator · 2021-06-11
COMPLETED
Combinatorial Therapy to Induce an HIV RemissionNCT04357821 · collaborator · 2020-08-01
COMPLETED
Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation StudyNCT02531295 · collaborator · 2019-05-15
TERMINATED
HIV Persistence in Lymph Node and Peripheral BloodNCT03426189 · collaborator · 2017-01-02
COMPLETED
Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV InfectionNCT03032575 · collaborator · 2017-01-01
COMPLETED
Use of Amphetamine-type Stimulants & Its Relationship With HIV Incidence and Antiretroviral Adherence Among MSM and TGNCT03198962 · collaborator · 2016-11-15
COMPLETED
Gender-Affirmative Transgender Care to Improve the HIV Treatment CascadeNCT03757117 · collaborator · 2016-10-01
COMPLETED
Impact of Everolimus on HIV Persistence Post Kidney or Liver TransplantNCT02429869 · collaborator · 2016-02-24
COMPLETED
Rilpivirine in Virologically Suppressed AdolescentsNCT03033368 · collaborator · 2015-07-01
UNKNOWN
Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation StudyNCT01944371 · collaborator · 2013-09-01
COMPLETED
RH and AdolescentsNCT02713750 · collaborator · 2013-03-01
COMPLETED
Exploration of the Neo-Vagina StudyNCT03049371 · collaborator · 2013-01-01
COMPLETED
Abacavir and Lamivudine PK in ChildrenNCT01656122 · collaborator · 2012-07-01
COMPLETED
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot StudyNCT01535235 · collaborator · 2012-02-01
COMPLETED
Atazavanir/Ritonavir-based HAART in ChildrenNCT01656109 · collaborator · 2011-07-01
COMPLETED
Second-line TherapyNCT01788891 · collaborator · 2011-01-01
COMPLETED
A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line RegimenNCT00931463 · collaborator · 2009-09-01
COMPLETED
Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic FailureNCT00735072 · collaborator · 2008-09-01
COMPLETED
Effect of Seminal Fluid on the Colon Wall; Implications for HIV TransmissionNCT01053741 · collaborator · 2008-03-01
COMPLETED
CDC HIV Testing Guidelines: Unresolved Ethical ConcernsNCT00564369 · collaborator · 2007-07-01
COMPLETED

Drugs studied in this sponsor's trials

9 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing amfAR, The Foundation for AIDS Research as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo2
abacavir1
disulfiram1
everolimus1
lamivudine1
lisinopril1
maraviroc1
raltegravir1
placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials abacavir RxCUI 190521 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial disulfiram RxCUI 3554 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial everolimus RxCUI 141704 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial lamivudine RxCUI 68244 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial lisinopril RxCUI 29046 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial maraviroc RxCUI 620216 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial raltegravir RxCUI 719872 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial rilpivirine RxCUI 1102270 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator24
lead sponsor1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.